Rotavirus (RV) is worldwide considered as the most important viral agent of acute gastroenteritis in children less than 5 y. Since 2006, the availability of anti-RV vaccines has deeply modified the incidence and economic burden of RV infection. In Europe, some countries have introduced an anti-RV vaccination program in the last 10 y. Although community acquired RV (CARV) disease is the most studied condition of RV infection, recently some authors have highlighted the importance of nosocomial RV (nRV) disease as an emerging public health issue. The aim of this review is to summarize the epidemiology of both CARV and nRV, in order to discuss the difficulty of a clear evaluation of the burden of the disease in absence of comparable data. In particular, we focused our attention to European studies regarding nRV in terms of divergences related to definition, report of incidence rate and methodological issues.

Gervasi, G., Capanna, A., Mita, V., Zaratti, L., Franco, E. (2016). Nosocomial rotavirus infection: An up to date evaluation of European studies. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 12(9), 2413-2418 [10.1080/21645515.2016.1183858].

Nosocomial rotavirus infection: An up to date evaluation of European studies

Zaratti L.;Franco E.
2016-01-01

Abstract

Rotavirus (RV) is worldwide considered as the most important viral agent of acute gastroenteritis in children less than 5 y. Since 2006, the availability of anti-RV vaccines has deeply modified the incidence and economic burden of RV infection. In Europe, some countries have introduced an anti-RV vaccination program in the last 10 y. Although community acquired RV (CARV) disease is the most studied condition of RV infection, recently some authors have highlighted the importance of nosocomial RV (nRV) disease as an emerging public health issue. The aim of this review is to summarize the epidemiology of both CARV and nRV, in order to discuss the difficulty of a clear evaluation of the burden of the disease in absence of comparable data. In particular, we focused our attention to European studies regarding nRV in terms of divergences related to definition, report of incidence rate and methodological issues.
2016
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/42 - IGIENE GENERALE E APPLICATA
English
hospital length of stay; nosocomial RV; rotavirus; Community-Acquired Infections; Cost of Illness; Cross Infection; Europe; Gastroenteritis; Humans; Rotavirus Infections
https://www.tandfonline.com/doi/full/10.1080/21645515.2016.1183858
Gervasi, G., Capanna, A., Mita, V., Zaratti, L., Franco, E. (2016). Nosocomial rotavirus infection: An up to date evaluation of European studies. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 12(9), 2413-2418 [10.1080/21645515.2016.1183858].
Gervasi, G; Capanna, A; Mita, V; Zaratti, L; Franco, E
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/233062
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact